학술논문

Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma
Document Type
Article
Source
In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 20 August 2023, 41(24):3998-4003)
Subject
Language
English
ISSN
15277755
0732183X